Edgewise Therapeutics (EWTX) traded down -1.7 % during a 24 hours period ending at 04:09 AM Central Europe on Tuesday 27th. One Edgewise Therapeutics stock can currently be bought for about USD 39.17 on popular exchanges. Current supply of Edgewise Therapeutics stocks is 108.6 mn. Edgewise Therapeutics has a current market capitalization of USD 4.3 bn and approximately USD 35.8 mn worth of Edgewise Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Edgewise Therapeutics has traded -4.49 % down. Simple moving average of last 200 days is at USD 35.93. The highest price of past 52 weeks was recorded at USD 48.51 on 09/17/2026. 52 weeks low was at USD 15.66 on 10/28/2025.
Here is how related stocks have performed in the past 24 hours:
Middleby (MIDD) traded up 0.27 % and now trades at USD 114.46. Middleby has a market capitalisation of USD 5.1 bn. Middleby has a current price to earnings ratio of 17.03.
Scholar Rock (SRRK) traded down -1.12 % and now trades at USD 41.71. Scholar Rock has a market capitalisation of USD 5.1 bn.
Floor & Decor (FND) traded down -0.71 % and now trades at USD 47.38. Current market capitalisation for Floor & Decor is USD 5.1 bn. Current price/earnings ratio for Floor & Decor is 22.15.
Billiontoone Cl (BLLN) traded up 1.98 % and now trades at USD 111.47. Billiontoone Cl has a market capitalisation of USD 5.1 bn. Current price/earnings ratio for Billiontoone Cl is 137.73.
Ptc Therapeutics (PTCT) traded down -3.89 % and now trades at USD 61.07. Current market capitalisation for Ptc Therapeutics is USD 5.1 bn.
About Edgewise Therapeutics
Edgewise Therapeutics, Inc. is a biotechnology company based in Boulder, Colorado, United States. The company specializes in developing novel, transformative therapies for the treatment of patients suffering from debilitating diseases. Their mission is to revolutionize the healthcare industry by providing innovative solutions to address unmet patient needs.